Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Nicholas

Showing results (31-40 of 165) with videos related to

Pageof 17
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 14, 2020
Defective CD19+CD24<sup>hi</sup>CD38<sup>hi</sup> transitional B-cell function in patients with relapsing-remitting MSMaria T Cencioni, Rehiana Ali, Richard Nicholas, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|March 24, 2007
Soft-tissue aneurysmal bone cyst: report of a case with t(5;17)(q33;p13)Dale A Ellison, Jeffrey R Sawyer, David M Parham, et al.
Drug Design, Development and Therapy|June 1, 2011
Development of oral immunomodulatory agents in the management of multiple sclerosisRichard Nicholas, Paolo Giannetti, Ali Alsanousi, et al.
Brain Communications|August 22, 2023
Patient-reported outcomes in multiple sclerosis: a prospective registry cohort studyAnnalaura Lerede, Jeff Rodgers, Rod M Middleton, et al.
Journal of Medical Economics|December 22, 2022
To wait, or too late? Modeling the effects of delayed ofatumumab treatment in relapsing-remitting multiple sclerosisStephen Maxwell Montgomery, Luke Green, Hajer Karoui, et al.
BMJ Supportive & Palliative Care|September 7, 2021
Influence of individual, illness and environmental factors on place of death among people with neurodegenerative diseases: a retrospective, observational, comparative cohort studyRichard Nicholas, Emma Nicholas, Mike Hannides, et al.
Plos Medicine|July 11, 2017
Patient-reported outcomes and survival in multiple sclerosis: A 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale-29Joel Raffel, Alison Wallace, Djordje Gveric, et al.
Acta Neuropathologica|June 1, 2011
The neuropathological basis of clinical progression in multiple sclerosisRichard Reynolds, Federico Roncaroli, Richard Nicholas, et al.
The Journal of the Arkansas Medical Society|February 5, 2015
MR imaging findings in diabetic muscle infarctionGitanjali Bajaj, Richard Nicholas, Tarun Pandey, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 17, 2024
University education facilitates uptake of disease-modifying therapies for multiple sclerosis: A community-based study using the UK MS RegisterJoyutpal Das, David J Rog, Rod Middleton, et al.
Pageof 17

Showing results (31-40 of 165) with videos related to

Sort By:
Pageof 17
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 14, 2020
Defective CD19+CD24<sup>hi</sup>CD38<sup>hi</sup> transitional B-cell function in patients with relapsing-remitting MSMaria T Cencioni, Rehiana Ali, Richard Nicholas, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|March 24, 2007
Soft-tissue aneurysmal bone cyst: report of a case with t(5;17)(q33;p13)Dale A Ellison, Jeffrey R Sawyer, David M Parham, et al.
Drug Design, Development and Therapy|June 1, 2011
Development of oral immunomodulatory agents in the management of multiple sclerosisRichard Nicholas, Paolo Giannetti, Ali Alsanousi, et al.
Brain Communications|August 22, 2023
Patient-reported outcomes in multiple sclerosis: a prospective registry cohort studyAnnalaura Lerede, Jeff Rodgers, Rod M Middleton, et al.
Journal of Medical Economics|December 22, 2022
To wait, or too late? Modeling the effects of delayed ofatumumab treatment in relapsing-remitting multiple sclerosisStephen Maxwell Montgomery, Luke Green, Hajer Karoui, et al.
BMJ Supportive & Palliative Care|September 7, 2021
Influence of individual, illness and environmental factors on place of death among people with neurodegenerative diseases: a retrospective, observational, comparative cohort studyRichard Nicholas, Emma Nicholas, Mike Hannides, et al.
Plos Medicine|July 11, 2017
Patient-reported outcomes and survival in multiple sclerosis: A 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale-29Joel Raffel, Alison Wallace, Djordje Gveric, et al.
Acta Neuropathologica|June 1, 2011
The neuropathological basis of clinical progression in multiple sclerosisRichard Reynolds, Federico Roncaroli, Richard Nicholas, et al.
The Journal of the Arkansas Medical Society|February 5, 2015
MR imaging findings in diabetic muscle infarctionGitanjali Bajaj, Richard Nicholas, Tarun Pandey, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 17, 2024
University education facilitates uptake of disease-modifying therapies for multiple sclerosis: A community-based study using the UK MS RegisterJoyutpal Das, David J Rog, Rod Middleton, et al.
Pageof 17